Elucidating the role of PBRM1 in NPC via RNA-seq transcriptomic sequencing
This study illuminates PBRM1's tumor suppressor role, highlighting the AKT-mTOR pathway and aerobic glycolysis as potential therapeutic targets in NPC.
Authors
- Wenhai Sun (ORCID: https://orcid.org/0000-0003-0458-0092)
- Yu Tang (ORCID: https://orcid.org/0000-0001-8152-1235)
- Yue Ren (ORCID: https://orcid.org/0000-0002-9354-4319)
- Qiu Qin (ORCID: https://orcid.org/0000-0003-0033-410X)
- Xiufeng Yang (ORCID: https://orcid.org/0000-0001-7521-954X)
- Xiaojiang Li (ORCID: https://orcid.org/0000-0002-7412-6795)
- Xinxin Wu
Institutions
- Zunyi Medical University (CN)
- Kunming Medical University (CN)
Publication Details
- Journal
- SLAS TECHNOLOGY
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1016/j.slast.2025.100386
- Primary Topic
- PI3K/AKT/mTOR signaling in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00